The annual report of Huaxi Biology will increase revenue without increasing profits. Does the road to medical beauty rely on hyaluronic acid or Li Jiaqi?

Reporter | Zheng Jie

Edit | Xie Xin

It should be noted that even health products cannot be exaggerated, let alone foods
.

Of course, this does not seem to affect the rush of consumers
.
The flagship store on Tmall under Huaxi Biology shows that the price of 6 bottles of sodium hyaluronate drinking water is 45.
9 yuan, and the first batch of sodium hyaluronate drinking water that will be on sale at 20 o'clock on March 22 has been sold out
.

According to the annual report, in 2020, Huaxi Biotech's operating cash flow was 705 million yuan, a year-on-year increase of 93.
24%
.
When a company is not short of money, how to use it is the key
.
The gross profit margin of Huaxi Biology's main business has been maintained at a relatively high level in these years.
In 2020, the gross profit rate of its main business will exceed 80%.
Therefore, some people in the industry compare it with Moutai
.

Similarly, the current medical beauty and domestic skin care products are in the air, and there is nothing wrong with investing in promotion and expanding revenue and profits.
However, there is a C-side gameplay on the C-side.
In the fast-moving market, competition has always been fierce; Huaxi is on the line of the Medical Academy.
The market share of biological hyaluronic acid injections is not as good as imported products
.
In the long run, no matter what wine is sold, the key is not the bottle, but the wine itself
.